summit study tirzepatide Effects of on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity SURMOUNT-1 Trial - Cardionerds Twitter

Patients were matched 1:4 to non-treated patients using a propensity score (PS) model

What is the potential of each market

Nooms new Microdose GLP-1Rx Program could be a game changer by leveraging low-dose compounded semaglutide with clinical coaching to reduce side effects and cut costs

Buy Now!

Most people who lose weight on GLP-1 medications regain it after stopping, making long-term use a realistic option for many

It stimulates insulin release when blood sugar is high, reduces glucagon secretion to prevent excessive glucose production and slows the rate at which food leaves the stomach, so you end up feeling full for longer and naturally eat less